WORCESTER, Mass., Aug. 20, 2007 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that is has been awarded new patents in Europe and Mexico.
